Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fortis

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Tumori|June 30, 1994
Intrapleural administration of interleukin-2 and LAK cells in locally advanced non-small-cell lung cancer. A case reportP Matteucci, M Tresoldi, G Chiesa, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients: II. Characterization of cells cultured ex vivo and their contribution to the in vivo immunomodulationC Fortis, E Ferrero, M Biffi, et al.
Cancer Letters|June 24, 1996
Increased interleukin-10 serum levels in patients with solid tumoursC Fortis, M Foppoli, L Gianotti, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|November 26, 1999
A prospective, randomized clinical trial on perioperative feeding with an arginine-, omega-3 fatty acid-, and RNA-enriched enteral diet: effect on host response and nutritional statusL Gianotti, M Braga, C Fortis, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients: I. Phenotypic and functional analysis of the peripheral blood mononuclear cellsC Fortis, E Ferrero, C Besana, et al.
British Journal of Cancer|October 1, 1996
Plasma nitrate plus nitrite changes during continuous intravenous infusion interleukin 2G Citterio, F Pellegatta, G D Lucca, et al.
The European Journal of Surgery = Acta Chirurgica|June 1, 1994
Thymopentin increases the survival of mice after allogeneic blood transfusion, bacterial gavage, and burn injuryM Braga, A Di Francesco, L Gianotti, et al.
Scandinavian Journal of Immunology|September 24, 2005
Natural killer-cell cytotoxicity in HIV-positive and HIV-negative patients with and without severe course of hepatitis B virus infectionG Morsica, S Tasca, P Biswas, et al.
European Journal of Immunology|November 11, 1999
Dual role of TNF-alpha in NK/LAK cell-mediated lysis of chronically HIV-infected U1 cells. Concomitant enhancement of HIV expression and sensitization of cell-mediated lysisC Fortis, P Biswas, L Soldini, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Treatment of advanced renal cell cancer with sequential intravenous recombinant interleukin-2 and subcutaneous alpha-interferonC Besana, A Borri, E Bucci, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Tumori|June 30, 1994
Intrapleural administration of interleukin-2 and LAK cells in locally advanced non-small-cell lung cancer. A case reportP Matteucci, M Tresoldi, G Chiesa, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients: II. Characterization of cells cultured ex vivo and their contribution to the in vivo immunomodulationC Fortis, E Ferrero, M Biffi, et al.
Cancer Letters|June 24, 1996
Increased interleukin-10 serum levels in patients with solid tumoursC Fortis, M Foppoli, L Gianotti, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|November 26, 1999
A prospective, randomized clinical trial on perioperative feeding with an arginine-, omega-3 fatty acid-, and RNA-enriched enteral diet: effect on host response and nutritional statusL Gianotti, M Braga, C Fortis, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients: I. Phenotypic and functional analysis of the peripheral blood mononuclear cellsC Fortis, E Ferrero, C Besana, et al.
British Journal of Cancer|October 1, 1996
Plasma nitrate plus nitrite changes during continuous intravenous infusion interleukin 2G Citterio, F Pellegatta, G D Lucca, et al.
The European Journal of Surgery = Acta Chirurgica|June 1, 1994
Thymopentin increases the survival of mice after allogeneic blood transfusion, bacterial gavage, and burn injuryM Braga, A Di Francesco, L Gianotti, et al.
Scandinavian Journal of Immunology|September 24, 2005
Natural killer-cell cytotoxicity in HIV-positive and HIV-negative patients with and without severe course of hepatitis B virus infectionG Morsica, S Tasca, P Biswas, et al.
European Journal of Immunology|November 11, 1999
Dual role of TNF-alpha in NK/LAK cell-mediated lysis of chronically HIV-infected U1 cells. Concomitant enhancement of HIV expression and sensitization of cell-mediated lysisC Fortis, P Biswas, L Soldini, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Treatment of advanced renal cell cancer with sequential intravenous recombinant interleukin-2 and subcutaneous alpha-interferonC Besana, A Borri, E Bucci, et al.
Pageof 2